Omega Therapeutics (OMGA) Revenue & Revenue Breakdown
Omega Therapeutics Revenue Highlights
Latest Revenue (Y)
$3.09M
Latest Revenue (Q)
$2.13M
Omega Therapeutics Revenue by Period
Omega Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $3.09M | 49.25% |
| 2022-12-31 | $2.07M | 1339.58% |
| 2021-12-31 | $144.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Omega Therapeutics generated $3.09M in revenue during NA 2023, up 49.25% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Omega Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $2.13M | -9.58% |
| 2024-03-31 | $2.36M | 138.62% |
| 2023-12-31 | $989.00K | 19.01% |
| 2023-09-30 | $831.00K | 9.49% |
| 2023-06-30 | $759.00K | 47.09% |
| 2023-03-31 | $516.00K | -29.80% |
| 2022-12-31 | $735.00K | 23.53% |
| 2022-09-30 | $595.00K | 25.00% |
| 2022-06-30 | $476.00K | 77.61% |
| 2022-03-31 | $268.00K | 86.11% |
| 2021-12-31 | $144.00K | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Omega Therapeutics generated $2.13M in revenue during Q2 2024, up -9.58% compared to the previous quarter, and up 413.57% compared to the same period a year ago.
Omega Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CNTA | Centessa Pharmaceuticals | $6.88M | - |
| OMGA | Omega Therapeutics | $3.09M | $2.13M |
| OBIO | Orchestra BioMed | $2.76M | $778.00K |
| MNOV | MediciNova | $1.00M | - |
| GPCR | Structure Therapeutics | - | - |
| PHVS | Pharvaris | - | - |
| AVTE | Aerovate Therapeutics | - | - |
| OLMA | Olema Pharmaceuticals | - | - |
| ELYM | Eliem Therapeutics | - | - |
| CVKD | Cadrenal Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| LRMR | Larimar Therapeutics | - | - |
| NVCT | Nuvectis Pharma | - | - |
| ELVN | Enliven Therapeutics | - | - |
| CMPX | Compass Therapeutics | - | - |
| MLTX | MoonLake Immunotherapeutics | - | - |
| PEPG | PepGen | - | - |
OMGA Revenue FAQ
What is Omega Therapeutics’s yearly revenue?
Omega Therapeutics's yearly revenue for 2023 was $3.09M, representing an increase of 49.25% compared to 2022. The company's yearly revenue for 2022 was $2.07M, representing an increase of 1339.58% compared to 2021. OMGA's yearly revenue for 2021 was $144K, representing an increase of 100.00% compared to 2020.
What is Omega Therapeutics’s quarterly revenue?
Omega Therapeutics's quarterly revenue for Q2 2024 was $2.13M, a -9.58% decrease from the previous quarter (Q1 2024), and a 181.16% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2.36M, a 138.62% increase from the previous quarter (Q4 2023), and a 357.36% increase year-over-year (Q1 2023). OMGA's quarterly revenue for Q4 2023 was $989K, a 19.01% increase from the previous quarter (Q3 2023), and a 34.56% increase year-over-year (Q4 2022).
What is Omega Therapeutics’s revenue growth rate?
Omega Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 2048.61%, and for the last 5 years (2019-2023) was 0%.